Amgros 2026 1 1184 A Tender Number 1

Deadline: 04 Mar 2026

Denmark

Ref. No.: 22939429

EMD:Ref Document

Bid Value: Ref Document

39 Days Left

Printed Materials And Stationery

Deadline: 04 Mar 2026

Ghana

Ref. No.: 22937767

EMD:Ref Document

Bid Value: Ref Document

39 Days Left

Correction Fluid Pen V3 Pressure Sensitive Adhesive Tapes With Plastic Base V4 Conforming To Is

Deadline: 04 Mar 2026

India

Ref. No.: 22904829

EMD:Ref Document

Bid Value: Ref Document

39 Days Left

251G001596 Etanercept 50 Mg 1 Ml Sol Inj Biossimilar Caneta Benepali Lot 1 Etanercept 50 Mg 1 Ml Sol Inj Biosimilar Pen Benepali

Deadline: 03 Mar 2026

Portugal

Ref. No.: 22890642

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Medicine Auction 170 Lots Insulinum Lispro Susp Inj In Prefilled Injector Pen 100U Ml Prefilled Injector Pens X 3Ml

Deadline: 03 Mar 2026

Romania

Ref. No.: 22890285

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Medicine Supply Framework Agreement 2026 Insulin Aspar

Deadline: 03 Mar 2026

Romania

Ref. No.: 22889638

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Supply Of Various Medicines Insulinum Glargine 100Ui Lantus Solostar Sol Inj In X 3 Ml Pre Filled Pen S

Deadline: 03 Mar 2026

Romania

Ref. No.: 22887700

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Attack Penetration Test Pen Test Kadaster Pen Testing Land Registry

Deadline: 03 Mar 2026

Netherlands

Ref. No.: 22886221

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

D Sanitary Medications Framework Agreement Exclusives Ii Sarilumab Kevzara Pen Syringe

Deadline: 03 Mar 2026

Spain

Ref. No.: 22885810

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Providing Access To Authorized Training With The Possibility Of Taking An Exam After Completing The Training And Obtaining A Certificate Confirming Knowledge From The Training

Deadline: 29 Jan 2026

Poland

Ref. No.: 22882870

EMD:Ref Document

Bid Value: Ref Document

5 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab Atc L04Ac07 For The Period December 1St 2023 November 30Th 2024 Plus Extension Option 1X12 Months Conclusi

Deadline: 03 Mar 2026

Germany

Ref. No.: 22862858

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab Atc L04Ac07 For The Period December 1St 2023 November 30Th 2024 Plus Extension Option 1X12 Months Conclusi

Deadline: 03 Mar 2026

Denmark

Ref. No.: 22862857

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab Atc L04Ac07 For The Period December 1St 2023 November 30Th 2024 Plus Extension Option 1X12 Months Conclusi

Deadline: 03 Mar 2026

Czech Republic

Ref. No.: 22862856

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab Atc L04Ac07 For The Period December 1St 2023 November 30Th 2024 Plus Extension Option 1X12 Months Conclusi

Deadline: 03 Mar 2026

Netherlands

Ref. No.: 22862855

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab Atc L04Ac07 For The Period December 1St 2023 November 30Th 2024 Plus Extension Option 1X12 Months Conclusi

Deadline: 03 Mar 2026

Germany

Ref. No.: 22862854

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Discover Tenders by Ballpoint Pens Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Ballpoint Pens Sector

Filter Your Search

FREE Trial plan for all new users!